Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages
    Reference: 20170198
    Release date: 26 August 2019

    Promoter – Financial Intermediary

    AMW GMBH

    Location

    Description

    AMW is a pharmaceutical company specialized in the development and manufacturing of innovative drug delivery systems, i.e. technologies aimed at the targeted delivery and controlled release of pharmaceutical compounds in order to improve their efficacy, safety and convenience. The company has a broad and diversified development pipeline, focused on providing solutions in strongly growing indications such as oncology, neurology, pain therapy and dermatology, which is expected to drive significant revenue growth in the future.

    Objectives

    The project will cover the company's substantial Research & Development (R&D) expenses relating to the development of existing and new products It will also include an additional R&D facility and purpose-built manufacturing technologies for innovative drug delivery systems together with associated laboratory and manufacturing equipment.

    Comments

    Loan foreseen under the European Fund for Strategic Investments (EFSI).

    Sector(s)

    • Services - Professional, scientific and technical activities

    Proposed EIB finance (Approximate amount)

    EUR 25 million

    Total cost (Approximate amount)

    EUR 52 million

    Environmental aspects

    The promoter's investments concern research, development and innovation activities that will be mainly carried out in existing facilities already authorised for similar activities and volumes and as such, do not require an Environmental Impact Assessment (EIA), according to the relevant EU Directives. However the Bank's services will verify during appraisal whether an EIA is required, as well as the screening decision of the competent authority.

    Procurement

    The promoter is a private company not operating in the utilities sector and not having a status of a contracting authority. Thus, it is not covered by the EU directives on procurement.

    Status

    Signed - 8/11/2017

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Related tags

    Germany Services